Eighteen paired serum samples submitted for serodiagnosis of current infection showed anomalous antibody results by complement fixation test when tested with a battery of agents (viruses, Mycoplasma pneumoniae, and chlamydia) selected for testing on the basis of the symptoms of the patient. Seventeen serum pairs showed a fourfold or greater rise in titer of antibody to two agents in the battery, and one showed only a twofold rise in titer of antibody to the identified causative agent but an eightfold rise in titer of antibody to a heterologous agent. In doubling dilution tests, a fourfold or greater increase in antibody titer between acute-phase (A) and convalescentphase (C) serum samples is considered to be a significant change in antibody concentration between the two samples and evidence for current infection with that agent. In our laboratory, serum samples received for serodiagnosis of viral infection are tested against a battery of antigens which may include, in addition to viral antigens, Mycoplasma pneumoniae and chlamydial antigens. The composition of the battery is chosen on the basis of the symptoms described by the physician on the specimen submittal form of the patient. Occasionally, a fourfold or greater rise in titer of antibody to more than one agent occurs. Such multiple rises could occur because of mixed infections, reactivation of a latent infection, cross-reactivity between antigens, or nonspecific polyclonal activation of memory cells from a previous infection with an unrelated agent. Certain cross-reactions between viruses are known, such as those between mumps virus and the parainfluenza group of viruses (7) and between herpes simplex (HSV) and varicella-zoster (VZV) viruses (26, 30 (11) with fluorescein-labeled sheep anti-human muchain-specific antibody (Wellcome Research Laboratories, Beckenham, England) and by enzyme immunoassay (Rubazyme-M; Abbott Laboratories, North Chicago, Ill.) in those cases in which one of the involved agents was rubella virus (RV). The serum pairs were also tested by indirect fluorescent-antibody technique with fluorescein-labeled rabbit antihuman gamma globulin (IFA-G) (not chain specific, Beckman Instruments, Fullerton, Calif.). The anticomplement immunofluorescence test (ACIF) as described (24), instead of the IFA-G test, was done to test for antibody to viruses of the herpes group to avoid the problem of Fc receptors. Fluorescein-labeled goat anti-guinea pig complement (Cappel Laboratories, Cochranville, Pa.) was used. CF and IFA-G tests were done by standard methods (13, 25) . With all the different fluorescent-antibody techniques (IFA-M, IFA-G, and ACIF), cells infected with the agent under study were used for the test antigen in antibody assays, and noninfected cells were used for control antigen. The tests were read by epifluorescence microscopy with Zeiss equipment. All serum samples were absorbed with IgG insolubilized by crosslinking with glutaraldehyde for removal of rheumatoid factor (9) before IgM tests. None of the sera was positive for antinuclear antibody, as determined by lack of fluorescence of nuclei of noninfected cells in the IFA-G and IFA-M tests. In selected cases, a hemagglutination inhibition test (22) , an enzyme immunoassay test (Rubazyme; Abbott Laboratories) for antibody to RV, and an enzyme immunoassay test for antibody to HSV, which was previously described (8), modified for use with an enzyme immunoassay PR50 automatic analyzer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio), and performed with alkaline phophatase-conjugated goat F(ab')2 fragment of anti-human gamma-chainspecific antibody (Sigma Chemical Co., St. Louis, Mo.), were done.
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Eighteen paired serum samples submitted for serodiagnosis of current infection showed anomalous antibody results by complement fixation test when tested with a battery of agents (viruses, Mycoplasma pneumoniae, and chlamydia) selected for testing on the basis of the symptoms of the patient. Seventeen serum pairs showed a fourfold or greater rise in titer of antibody to two agents in the battery, and one showed only a twofold rise in titer of antibody to the identified causative agent but an eightfold rise in titer of antibody to a heterologous agent.
The 18 serum pairs were tested for IgM antibody to the two involved agents to determine whether IgM antibody tests would better distinguish the probable cause of the current infection. The serum pairs were separated into three groups based on their IgM responses. Group I consisted of six serum pairs with IgM antibody to both agents, four pairs of which showed a fourfold or greater rise in titer of IgM antibody to both agents, and two of which showed a rise in titer of IgM antibody to only one of the two agents. Group II consisted of 10 serum pairs with IgM antibody to one of the two agents, 7 pairs of which showed a fourfold or greater rise in titer of IgM antibody to the agent. Group III consisted of two serum pairs with no IgM antibody to either agent. Results show that determination of presence or absence of IgM antibody per se or demonstration of a fourfold or greater rise in specific IgM antibody titer does not always help in distinguishing the causative agent in current infections.
In doubling dilution tests, a fourfold or greater increase in antibody titer between acute-phase (A) and convalescentphase (C) serum samples is considered to be a significant change in antibody concentration between the two samples and evidence for current infection with that agent. In our laboratory, serum samples received for serodiagnosis of viral infection are tested against a battery of antigens which may include, in addition to viral antigens, Mycoplasma pneumoniae and chlamydial antigens. The composition of the battery is chosen on the basis of the symptoms described by the physician on the specimen submittal form of the patient. Occasionally, a fourfold or greater rise in titer of antibody to more than one agent occurs. Such multiple rises could occur because of mixed infections, reactivation of a latent infection, cross-reactivity between antigens, or nonspecific polyclonal activation of memory cells from a previous infection with an unrelated agent. Certain cross-reactions between viruses are known, such as those between mumps virus and the parainfluenza group of viruses (7) and between herpes simplex (HSV) and varicella-zoster (VZV) viruses (26, 30 (22) , an enzyme immunoassay test (Rubazyme; Abbott Laboratories) for antibody to RV, and an enzyme immunoassay test for antibody to HSV, which was previously described (8) , modified for use with an enzyme immunoassay PR50 automatic analyzer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio), and performed with alkaline phophatase-conjugated goat F(ab')2 fragment of anti-human gamma-chainspecific antibody (Sigma Chemical Co., St. Louis, Mo.), were done. The mean collection day of the A samples from date of onset of symptoms was 5.8 ± 4.1 days, and the mean collection day of the C samples from date of onset of symptoms was 22.3 + 9.4 days ( Table 1 ). The serum samples were collected aseptically and stored in sterile containers at 4°C. The ages of the donors of the serum pairs ranged from 2 to 74 years (Table 1) . Viral isolation. Specimens for virus isolation (two cases) or identification (skin lesion slides, two cases) were submitted along with the corresponding serum samples. Human fetal diploid lung or primary monkey kidney cultures were used for isolation. Identification of the isolates or viral antigen in the skin lesions was made by the direct fluorescent antibody technique, using fluorescein-labeled anti-HSV antibody or fluorescein-labeled antibody to cytomegalovirus (CMV) prepared in hamsters or mice in our laboratory. Controls included noninfected and infected human fetal diploid lung cells. RESULTS Virus isolation. CMV was isolated from the urine of patient 1, and HSV was isolated from the throat of patient 9 ( Table  2) . Slides of skin lesions were positive for HSV in patient 8 and negative in patient 12 The incidence of dual antibody titer rises in our laboratory over the past 2 years has been 4.6% (26 cases with dual titer rises of 555 total cases with titer rises). More rarely encountered are multiple (triple or more antibody titer rises). In a recent example, the paired serum samples of a 30-year-old male patient with high fever and rash showed fourfold-orgreater rises in CF titers of antibody to five agents (MP, RSV, CMV, HSV, and measles), a low titer in the C sample (titer 10) of IgM to MP only, and a rise in IFA-G titer of antibody to RSV. The other IFA-G titers were high and standing. The pattern of IFA results for antibody to EpsteinBarr viral antigens indicated a past infection with no evidence of reactivation (14) . In this example, the multiple CF antibody titer rises appear to be nonspecific polyclonal activation of antibody formation due to causes unknown.
The present study illustrates the difficulties encountered with 18 paired serum samples in the interpretation of results. In the six cases in which IgM antibody to both agents was present ( (15) , it is only rarely present in usual recurrent or reactivated HSV infection (10, 27 (20, 23, 28) . In patient 8, HSV infection was diagnosed by fluorescent-antibody staining of HSV antigen in tissue from a skin lesion. Since IgM antibody to HSV was absent, it was probably a recurrent HSV infection with possible concurrent CMV infection or possibly nonspecific polyclonal activation of the CMV antibody response by HSV. Patient 9 (HSV-mumps combination) apparently had a reactivated HSV infection with polyclonal stimulation by HSV of memory cells committed to production of antimumps viral antibody. There was a high standing titer of IgM antibody to mumps virus (A, 128; C, 128), no IgM antibody to HSV was isolated from the throat of this patient, but HSV was. However, it is possible that neither agent was the causative agent of the encephalitis. Latent HSV infection is often reactivated under conditions of stress, which might occur in a sick child, and although HSV can be isolated from the throat, it was not necessarily the causative agent of the encephalitis. HSV is reported to be a mitogen, as demonstrated by [3H]thymidine incorporation by mouse B lymphocytes after reaction with HSV in vitro (16) . It is noteworthy that HSV appeared in 6 cases (Table 2) in combination with seemingly unrelated agents.
In patient 11, although a low level of IgM antibody to HSV (titer of 8) was present in the C sample, the clinical findings were more compatible with recurrent VZV (zoster) infection. IgM antibody is usually present in cases of infection with herpes zoster virus (3, 5, 27) ; however, it appears to arise more slowly than in cases of infection with varicella virus (31) . In a report by Sundqvist (31) , none of the zoster virus-infected patients had IgM antibody earlier than 10 days after onset of symptoms. In that study, 21 of 25 zoster patients became positive for IgM antibody to VZV. In patient 11 (Table 1) , the A sample and the C sample were taken 1 and 10 days, respectively after onset of symptoms, possibly too early for an IgM response. The dual rises in CF titer of antibody to HSV and VZV are assumed due to shared antigens.
In addition to HSV, other agents appearing in Table 2 are reported to act as mitogenic agents for mouse B lymphocytes. MP acted as a B-cell mitogen for mouse and guinea pig lymphocytes and induced polyclonal antibody formation in mouse spleen cells (4); isolated hemagglutinin glycoproteins from Flu A subtypes HON1, HlNl, H2N2, and H3N2 and from Flu B were mitogenic for mouse lymphocytes (1, 6) , as were the isolated hemagglutinin-neuraminidase and fusion glycoproteins of Sendai virus, a paramyxovirus type 1 virus (17) . Representatives of these agents appeared in the serum of patients 2, 3, 4, 5, 6, and 16 .
Recent studies by other investigators report on stimulation of IgM antibody to RV during infection with Epstein-Barr virus (18) , stimulation of IgM antibody to HSV types 1 and 2 and CMV during vaccination of a child with VZV, and stimulation of IgM antibody to CMV in HSV type 1 stomatitis (19) . Other reports include studies on the production of IgM antibody to CMV in VZV infections (12) , rises in CF titers of antibody to measles virus and RV in cases of ulcerative colitis and chronic active hepatitis (32), increased production, by lymphocytes in vitro of patients in cases of measles and varicella, of antibody to the etiological virus as well as to unrelated viruses (varicella, measles, rubella, and mumps viruses) (2) . As more is learned about basic mechanisms in isotype switching and the development, expression, and activation of memory cells, anomalous results such as those described here may be explained. This study illustrates the importance of testing for antibody to a battery of likely agents rather than testing for antibody to only one suspected agent; this study also indicates that no one test or combination of tests can always resolve problems in interpretation of laboratory results.
